My research vision is to use chemistry as a tool to solve biomedical problems. Particularly, I am interested in studying nanoparticle-mediated drug delivery at cellular level using innovative chemistry approaches. I believe modern tools such as bioorthogonal chemistry provide exciting opportunities to understand how nanoparticles are internalized by cells, and subsequently trafficked inside cells. Furthermore, I would like to apply these fundamental understanding in the next-generation nanotherapeutics development. My extensive combinational expertise in chemistry and nanomedicine enables these exploration at the bio-nano interface. If you are a passionate researcher interested in these topics, welcome to join us!
Dr. Cheng completed her PhD in February 2023, with joint degree from the University of Helsinki and the University of Groningen under the supervision of Prof. Helder Santos. She is an expert on nanomedicine for cancer immunotherapy.
Project supported by The Research Fund of the Finnish Red Cross Blood Service